dipyridamole has been researched along with Hypersensitivity, Type III in 5 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of the antiplatelet agents ticlopidine and dipyridamole on immune complex glomerulonephritis in rats was evaluated." | 7.67 | Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats. ( Asaka, M; Iida, H; Izumino, K; Mizumura, Y; Sasayama, S, 1986) |
| "The effect of the antiplatelet agents, ticlopidine and dipyridamole, on nephrotoxic serum nephritis (NTN) was evaluated in rats." | 7.67 | Effect of the antiplatelet agents ticlopidine and dipyridamole on nephrotoxic serum nephritis in rats. ( Asaka, M; Iida, H; Izumino, K; Sasayama, S, 1987) |
| "The effect of the antiplatelet agents ticlopidine and dipyridamole on immune complex glomerulonephritis in rats was evaluated." | 3.67 | Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats. ( Asaka, M; Iida, H; Izumino, K; Mizumura, Y; Sasayama, S, 1986) |
| "The effect of the antiplatelet agents, ticlopidine and dipyridamole, on nephrotoxic serum nephritis (NTN) was evaluated in rats." | 3.67 | Effect of the antiplatelet agents ticlopidine and dipyridamole on nephrotoxic serum nephritis in rats. ( Asaka, M; Iida, H; Izumino, K; Sasayama, S, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ogawa, S | 1 |
| Naruse, T | 1 |
| Sanaka, T | 1 |
| Nakano, Y | 1 |
| Nishimura, H | 1 |
| Shinobe, M | 1 |
| Higuchi, C | 1 |
| Omata, M | 1 |
| Nihei, H | 1 |
| Sugino, N | 1 |
| Simon, NM | 1 |
| Rosenberg, MJ | 1 |
| Izumino, K | 2 |
| Iida, H | 2 |
| Asaka, M | 2 |
| Mizumura, Y | 1 |
| Sasayama, S | 2 |
1 review available for dipyridamole and Hypersensitivity, Type III
| Article | Year |
|---|---|
Medical treatment of glomerular diseases.
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Azathioprine; Child; Chlorambucil; Cyclophosphamid | 1978 |
4 other studies available for dipyridamole and Hypersensitivity, Type III
| Article | Year |
|---|---|
Effects of various antiplatelet drugs and defibrinating agent on experimental glomerulonephritis in rats.
Topics: Animals; Anticoagulants; Aspirin; Batroxobin; Blood Platelets; Dipyridamole; Glomerulonephritis; Imm | 1982 |
Therapeutic effect of a newly developed antioxidative agent (OPC-15161) on experimental immune complex nephritis.
Topics: Animals; Antioxidants; Dipyridamole; Free Radical Scavengers; Immune Complex Diseases; Kidney; Kidne | 1997 |
Effect of the antiplatelet agents ticlopidine and dipyridamole on experimental immune complex glomerulonephritis in rats.
Topics: Animals; Antibodies; Antigen-Antibody Complex; Cattle; Creatinine; Dipyridamole; Fluorescent Antibod | 1986 |
Effect of the antiplatelet agents ticlopidine and dipyridamole on nephrotoxic serum nephritis in rats.
Topics: Animals; Dipyridamole; Immune Complex Diseases; Nephritis; Platelet Aggregation; Proteinuria; Rats; | 1987 |